(Q60976770)
Statements
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate (English)
Litzow MR
Gertz MA
Lacy MQ
Ansell SM
Elliott MA
Gastineau DA
Inwards DJ
Micallef IN
1 December 2004